Skip to content

Comparing the Effects of Esketamine and Dexmedetomidine on the Incidence of Delirium in Elderly Patients in the ICU After General Anesthesia: A Randomized Controlled Single-Blind Clinical Trial

Comparing the Effects of Esketamine and Dexmedetomidine on the Incidence of Delirium in Elderly Patients in the ICU After General Anesthesia: A Randomized Controlled Single-Blind Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102616
Enrollment
Unknown
Registered
2025-05-16
Start date
2024-09-19
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Group D:Sedation with dexmedetomidine for patients transferred to the AICU after elective surgery under general anesthesia.
Group E:Sedation with esketamine for patients transferred to the AICU after elective surgery under general anesthesia.

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) The subjects voluntarily cooperate with the study and sign the informed consent form; (2) No gender limitation, aged 60 to 90; (3) Transferred to AICU within 24 hours after elective surgery under general anesthesia; (4) Requires sedation treatment due to medical conditions.

Exclusion criteria

Exclusion criteria: 1.Uncontrolled or poorly controlled hypertension (systolic blood pressure >=180 mmHg or diastolic blood pressure >=110 mmHg) or intracranial hypertension; 2.Severe heart failure or second- or third-degree atrioventricular block; heart rate <55 bpm; 3.Acute coronary syndromes (e.g., unstable angina or acute myocardial infarction); 4.Glaucoma or penetrating eye injuries; 5.Untreated or inadequately treated hyperthyroidism or hypothyroidism; 6.Severe central nervous system diseases (e.g., acute stroke, uncontrolled epilepsy, severe dementia); 7.Allergy or contraindication to study drugs such as dexmedetomidine or esketamine and their components; 8.History of alcoholism, drug addiction, or substance abuse; 9.Severe visual or auditory impairments, or inability to communicate in Mandarin or Cantonese; 10.Severe preoperative infection; 11.Patients deemed unsuitable for participation by the investigator.

Design outcomes

Primary

MeasureTime frame
The incidence of postoperative delirium;

Secondary

MeasureTime frame
Incidence of Anesthesia-Related Complications in the AICU;Postoperative recovery status;Changes in plasma inflammatory factor levels;Pain score;

Countries

China

Contacts

Public ContactLi Le

Zhujiang Hospital of Southern Medical University

lile2020@i.smu.edu.cn+86 13242805989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026